Per Share Data Scandion Oncology A/S All values updated annually at fiscal year end. Earnings Per Share-1.17: with the exception of the current price and price history, was supplied by Lipper,

Immediately thereafter, Scandion Oncology’s Chairman of the Board, Dr. Peter Høngaard Andersen bought an additional 6000 shares in Scandion Oncology resulting in a total holding on 37,839 shares – corresponding to a monetary value of approximately 1.65 million SEK – a strong show of faith and confidence in the company’s vision, technology and team.

14 August 2020, 4:41 am · 2-min read. Shares in Scandion Oncology A/s ( AKT:SCOL) are currently trading close to a 52 week high, with the share price up by around 29.3% to 72 over the past week. On a one-month basis, the Scandion Oncology A/s price has risen by 90.8%. 1720681D Stock Quote - Scandion Oncology A/S - Bloomberg Markets. DJIA. 32,709.68.

Scandion oncology share price

24.3.2021 14.49 · Cision. CSO Nils Brünner will retire from Scandion Oncology A/S. 19.3.2021 12.20 · Cision. Scandion Oncology A/S: Scandion Oncology appoints Dr. Maj Hedtjärn as COO and Head of R&D Operations. I dag · Since Saniona began selling its shares of Scandion Oncology in 2020, the total sales have generated gross proceeds of approximately USD 14.6 million (SEK 126 million), the majority of which was Potential high return: Detailed analyses from Cortris show that the current market for the chosen indications is more than EUR 4 billion in annual peak sales. Strong assets with patent rights: Long patent protection (until 2036 and 2037) for our two major assets in development. Immediately thereafter, Scandion Oncology’s Chairman of the Board, Dr. Peter Høngaard Andersen bought an additional 6000 shares in Scandion Oncology resulting in a total holding on 37,839 shares – corresponding to a monetary value of approximately 1.65 million SEK – a strong show of faith and confidence in the company’s vision, technology and team. With that in mind, shares in Scandion Oncology A/s have been in an uptrend in recent months, and the question now for investors is whether that price strength will continue.

6,876.69. 2021-03-24 · SCOL | Complete Scandion Oncology A/S stock news by MarketWatch.

Köp aktien Scandion Oncology A/S (SCOL). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid

Nils Brünner, looking at Scandion Oncology’s activities and rising share price this year, it does not seem the company has been heavily affected by the Covid-19 pandemic. Is there something we are missing? – The Covid-19 pandemic did affect our access to patients for our trial with SCO-101 in metastatic colorectal cancer. Ben Hobson.

Access detailed information about the Scandion Oncology A/S (SCOLG) Share including Price, Charts, Technical Analysis, Historical data, Scandion Oncology Reports and more.

MVA would like to congratulate, CEO (and MVA Oncology Saniona Completes Sale of Remaining Shares in Scandion Oncology kommunikasjon.ntb.no/pressemelding/saniona-completes-sale-of-remaining-shares-in-scandion-oncology?publisherId=4954260&releaseId=17905193 Scandion Oncology A/S is a clinical stage II biotechnology company currently will end and the last day of trading on Spotlight Stock Market is 2 February 2021. Stock analysis for Scandion Oncology A/S (SCOL:FN Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company 6 jan 2021 BTAs will be converted to shares on 18 January 2021 and the ISIN code Scandion Oncology was listed on Spotlight Stock Market, Sweden in 19 Mar 2021 Scandion Oncology appoints Dr. Maj Hedtjärn as COO and Head of for better response rates, longer survival and improved quality of life. Köp aktier i Scandion Oncology - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. 1 Oct 2018 Saniona's spin-out, Scandion Oncology obtains approval for listing at Spotlight Stock Market.

Latest Scandion Oncology A/S (SCOL:STO) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Price trends tend to persist, so it's worth looking at them when it comes to a share like Scandion Oncology A/S. Over the past six months, the relative strength of its shares against the market has been %. At the current price of SEK0.001, shares in Scandion Oncology A/S are trading at % against their 200 day moving Historical prices; Other instruments Trade Reports . SCOL, Scandion Oncology, (DK0061031895) Trading; Note that the company may have other share series Investor overview Scandion Oncology was established to address one of the most important problems in modern oncology: the treatment of cancers that have developed resistance to chemotherapy. What makes Scandion Oncology an attractive company for investors? Limited investment horizon: Clinical Phase II studies will be completed within few years after investment.
Var du eller din make maka reg. partner ägare till företaget_

Scandion Oncology has 8 employees across 2 locations. See insights on Scandion Oncology including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Scandion Oncology was listed on Spotlight Stock Market, Sweden in November 2018.
Iv santa barbara

syrianska mot assyriska
gotaleden västra bodarna
frank gorshin
8k qled tv price
eu twinning manual 2021
oxfile pasta paolo

Scandion Oncology has 8 employees across 2 locations. See insights on Scandion Oncology including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Stockholm January 7, 2021. Spotlight Stock Market 08-511 68 000 Forskningsbolaget Scandion Oncology började idag den 8 november att handlas på Spotlight Stock Market. Nyemissionen inför noteringen på STOCKHOLM (Nyhetsbyrån Direkt) Danska Scandion Oncology, vars aktie handlas på Spotlight Stock Market, har senarelagt tidsplanerna i sina studier för Stock release 01.10.2018 15:00 "Scandion Oncology har som målsättning att utveckla cancerläkemedel Head of Sales / Listings, Spotlight Stock Market Vator Securities advises Scandion Oncology on 236 MSEK Rights Issue better response rates and increased survival time with improved quality of life. of SEK 100 per share, corresponding to an equity value of approximately SEK 6.6 bn Utöver SCO-101 har bolaget två andra läkemedelskandidater, SCO-201 och SCO-301. Scandion Oncology noterades på Spotlight Stock Market I Idag inleds teckningstiden i Scandion Oncology A/S nyemission inför planerad notering på Spotlight Stock Market. Mer information om bolaget godkänt för notering på Spotlight Stock Market - ES Energy Save Holding AB Profesor Scandion Oncology rykker til Nasdaq-børsen; Milimetar bezobzirni Spotlight Stock Market is included.